New mosquito-targeting insecticide offers hope of 'malaria-free' future

Image
ANI Washington
Last Updated : May 21 2015 | 8:32 PM IST

Researchers have come up with a new antibody insecticide that targets malaria mosquitoes.

Recent progress in halting the spread of the disease has hinged on the use of insecticide-treated bed nets and spraying programmes that target the insect that spreads the disease, the African malaria mosquito (Anopheles gambiae).

However, the insects are fighting back, developing resistance to insecticides such as pyrethroid that control their numbers, forcing Brian Foy and Jacob Meyers from Colorado State University to think of alternative control strategies.

The duo decided to test whether antibodies targeted at a key component of the malaria mosquito's nervous system could be fed to the insects in a blood meal to kill them.

Identifying a glutamate gated chloride channel (the mosquito glutamate gated chloride channel - AgGluCl), which is an essential component of the insect's nervous system, to be the target of their novel strategy the duo decided to generate antibodies that specifically targeted a portion of the protein that is exposed on the surface of nerves to try to exterminate the disease carriers.

However, Meyers admits that the strategy was risky as antibodies against a single mosquito antigen have never been shown to have mosquitocidal properties before and the majority of previous research had focused on midgut antigens, while they were targeting a neuronal antigen expressed only in tissues found outside of the midgut.

Having shown that antibodies targeted to the glutamate gated chloride channel in blood meals can be effective insecticides, Meyers and Foy are keen to find out if antibody-laced blood meals are equally deadly in real life.

Meyers said that cattle are a major blood meal source for multiple malaria vectors, explaining that any malaria-harbouring mosquito that consumed blood carrying the toxic antibodies during the malaria parasite's incubation period would die, disrupting transmission of the disease and offering hope of a malaria-free future for generations to come.

The study appears in The Journal of Experimental Biology.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2015 | 2:40 PM IST

Next Story